A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

An FDA advisory committee ruled in two separate votes that two belantamab mafodotin combination regimens should not be used in the proposed dosages for previously treated adult patients with ...

The recall applies to three types of Power Stick deodorant, due to "cGMP deviations," meaning the product did not meet ...

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

The FDA's Oncologic Drugs Advisory Committee has casted their votes on the utilization of certain treatments in the multiple ...

Drinking black coffee offers benefits that may extend your life, but a new study found that adding sugar and cream may offset ...

More than 67,000 cases of deodorant sold at major retailers are being recalled due to a manufacturing issue. According to a ...

Some contained high levels of caffeine -- up to 665 mg per serving, or more than six cups of coffee. Two of the 12 products ...

The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have led to some women avoiding the option, even if it could help them.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Despite a phase 3 flop, Bristol Myers Squibb—encouraged by “clinically meaningful results” and bruised by three other recent pivotal trial failures—still plans to discuss a potential approval filin | ...

The Food and Drug Administration has updated their recall of a batch of Dubai chocolate spread to Class I, their highest ...